ryan braun wide getty

In focusing on Braun, Major League Baseball is abandoning the principles of its drug testing/enforcement program


Been doing some more thinking about the story this morning about how Major League Baseball is laser-focused on Ryan Braun in the Biogenesis investigation, to the point where it is considering giving players immunity in an effort to nab him and some of the bigger fish.

As a basic premise, I don’t have a real problem with that. This is how police work is usually done: get the small fish to flip on the big fish and so forth. I think this differs from the organized crime analogy in that here the “big fish” is only one player whose violation is no different in kind or magnitude than that of any other person cheating — and, as such, going after Braun like this is likely to cause MLB to overlook multiple more cheaters who collectively represent a greater ill to baseball than one more famous cheater — but that’s their prerogative. If they get the goods on Braun and punish him, fine, he’s punished.

All of that said, in pursuing things in such a way it’s inescapable that Major League Baseball is abandoning some of the core principles of the drug program as currently constructed.

For one thing: zero tolerance. The most adamant anti-PED folks on the planet, including WADA and USADA have spent decades telling us that zero tolerance is critical to any drug testing regime and that only through zero tolerance can you have a level competitive landscape. In singling out Braun, however, and standing willing to grant immunity to some players in order to get him, Major League Baseball is abandoning that principle. It is saying that some cheaters are more important than others. Which is the same as saying that some cheating will, in effect, be tolerated and will go unpunished.

And maybe Major League Baseball is fine with that. If so, they should say so. And if so they should cease selectively applying the standards of zero tolerance. I mean, if MLB is satisfied that it can weigh the words and determine the truthfulness of one player’s word over another’s and that it can mete out differential enforcement like this and not harm the very essence of the Joint Drug Agreement, surely it can listen to defenses of inadvertent contamination and accidental ingestion of various stimulants and PEDs, can it not? Now Bud Selig says that it can’t do that for risk of imperiling zero tolerance principles. But if the Biogenesis investigation throws such principles over the side, what is left to protect?

Also being abandoned right now: the anonymity of the testing and enforcement process.  Major League Baseball’s fixation on Braun is of such a high pitch, it appears, that it was deemed unique and newsworthy by someone privy to the process and thus was leaked to Bob Nightengale of USA Today. Since when is that acceptable? The last time news of a drug investigation/enforcement proceeding was made public it led to MLB being publicly embarrassed when that outfielder from Milwaukee beat the rap. How did that turn out for you, Mr. Selig? And how has it turned out for that outfielder, whose name will always be mud to some folks regardless of what the future holds?

If Ryan Braun cheated — and if Major League Baseball can prove it — yes, he should absolutely be punished. And at this point, if what Nightengale is reporting is true, I’d lay better odds on Braun getting popped than him getting off.  But in getting that head on a platter it’s inescapable that Major League Baseball is transforming its drug testing and enforcement regime from a clinically-based program into a police operation.  And in doing so, it appears willing to abandon zero tolerance, anonymity, uniform enforcement and everything the league tells us is so good about the Joint Drug Agreement in the first place.

Hope it’s worth it, guys.

Orioles have reached out to Yovani Gallardo

Yovani Gallardo
AP Photo/Tony Gutierrez

From Jon Heyman of CBS Sports comes word that the Orioles “like” free agent starter Yovani Gallardo and “have reached out to him” to gauge his interest in coming to Baltimore and what that might cost.

Gallardo rejected a one-year, $15.8 million qualifying offer from the Rangers earlier this month and so his free agency is tied to draft pick compensation, but that shouldn’t hurt his bottom line all that much.

The 29-year-old right-hander posted a solid 3.42 ERA in 184 1/3 innings (33 starts) this past season for Texas and he pitched well in his one ALDS start.

Heyman reported a few weeks ago that the Diamondbacks are interested, and the Cubs, Blue Jays, and Dodgers were tied to him just ahead of the July 31 trade deadline.

Cubs, Cardinals, Giants, Dodgers, and Red Sox all showing serious interest in David Price

AP Photo/Tim Donnelly

David Price has expressed a desire to return to Toronto, where he finished out the 2015 season, but FOX Sports’ Ken Rosenthal writes Wednesday that the Blue Jays “are not expected to be a major factor in his free agency.”

The teams that should be considered serious suitors, per Rosenthal, are the Cubs, Cardinals, Giants, Dodgers, and Red Sox — all deep-pocketed teams looking to contend in 2016. Money is apparently the issue for the Blue Jays, who are currently owned by Rogers Communications.

Price registered an outstanding 2.45 ERA, 1.076 WHIP, and 225/47 K/BB ratio in 220 1/3 innings (32 starts) this past season between the Tigers and Jays, finishing second in the American League Cy Young Award race behind Dallas Keuchel of the Astros.

The 30-year-old left-hander is probably looking for a six- or seven-year contract worth more than $25 million per season. He is represented by agent Bo McKinnis.

Marlins have begun extension talks with Dee Gordon

Dee Gordon
AP Photo/Alex Brandon

Barry Jackson of the Miami Herald wrote three weeks ago that the Marlins were probably going to explore an extension this winter with second baseman Dee Gordon. And it sounds like those talks are underway.

Via beat writer Joe Frisaro of MLB.com:

As a guest on MLB Network’s “Hot Stove” show Wednesday morning, Gordon confirmed his camp has been in talks with the Marlins regarding a multiyear deal. A source told MLB.com that the discussions are preliminary and have just recently started.

“My agent is doing the talking,” Gordon said on the show. “They’re just keeping me in the loop. I think it’s going pretty well right now. We’ll see how that goes. I’m just playing the waiting game. We’re going to do the right thing.”

The 27-year-old carries three more seasons of salary arbitration, so there’s no real rush to get something done before next spring. Gordon carries quite a bit of leverage after posting a career-best .333/.359/.418 slash line in 145 games this past season for the Fish. He led all major leaguers in hits (205) and stolen bases (58).

Braves sign Bud Norris to one-year contract

Bud Norris

Bud Norris has found a home for his attempt at a bounceback season, signing a one-year deal with the Braves. Jon Heyman of CBSSports.com says it’s worth $2.5 million, which is a huge cut from his $8.8 million salary this year.

Norris had established himself as a solid mid-rotation starter from 2009-2014, but had a brutal 2015 season split between the Orioles and Padres with a 6.72 ERA in 83 innings and a late-season move to the bullpen.

In announcing the signing the Braves referred to Norris as a starting pitcher, so joining the rotation for a rebuilding team gives him a chance to get his career back on track with an eye on hitting the open market as a free agent again next offseason. And if he fares well, the Braves could use him to add a prospect or two at the trade deadline.